Table 2 Previous attempts of buildup phase with HB venom
From: Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab
Week no. | Premedication | HB venom cumulative dose (mcg) | Adverse Reactions |
|---|---|---|---|
1 | 4.11 | None | |
2 | 10 | Ocular itching | |
3 | 5 | Anaphylaxis | |
5 | Terfenadine | 4.11 | None |
6 | Terfenadine | 10 | None |
7 | Terfenadine | 10 | Anaphylaxis |